Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma

NCT03074825 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped The results fell short of expectations.

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: Chiauranib

Sponsor

Chipscreen Biosciences, Ltd.